What is Jet Lag Treatment Market?
The speedy growth in the number of air travellers along with least side-effects or complexities of drugs has been the primary factors driving the jet lag treatment market. Jet lag is a physical disease that happens when the body’s internal clock gets thrown off by a new time zone. Jet Lag Treatment is used to prevent jet lag and nip its sleepy symptoms in the bud. A person may feel drowsy, tired, irritable, lethargic, and slightly disoriented. Then people travel rapidly across time zones or when their sleep is disrupted, for example, because of shift work. The features of jet lag include fatigue, headache, irritability, poor concentration, gastrointestinal disorders, cognitive deficits, and sleep difficulties
The market study is being classified by Type (Light therapy and Medications), by Application (Hospital Pharmacies, Retail Pharmacies, Online Sales and Drug Stores) and major geographies with country level break-up.
Natrol Inc. (United States), Lucimed (Belgium), Re-Time Pty Ltd. (Australia), Neurim Pharmaceuticals Ltd. (Israel), Pulse Pharmaceuticals Pvt. Ltd. (India), Flynn Pharma Ltd. (United Kingdom), Northern Light Technologies (Australia), Fidia Farmaceutici S.P.A. (Italy), Aspen Pharmacare Holdings Ltd. (South Africa) and Schiff Nutrition International Inc.(United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are The Litebook Company Ltd. (Canada).
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Analyst at AMA have segmented the market study of Global Jet Lag Treatment market by Type, Application and Region.
On the basis of geography, the market of Jet Lag Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing geriatric population across the globe
- An increasing issue of jet lag among the populace such as pilots, flight attendants and business travellers
- New technological innovations in jet lag treatment market such as the introduction of wearable light therapy devices
- Strict governmental rules and regulations on Jet Lag treatment
- The rapid increase in the number of air travellers along with minimal side-effects or complications of drugs has been the primary factors driving the jet lag treatment market.
- Lack of awareness regarding the Jet Lag
Key Target AudienceNew entrants/investors, Analysts and strategic business planners, Jet Lag Treatment Provider, Government regulatory and research organizations and End-use industry
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase